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Abstract 
Periodontitis is a multifactorial disease with microbial dental plaque as the initiator of periodontal disease. However, the 
manifestation and progression of the disease is influenced by a wide variety of determinants and factors. The strongest 
type of causal relationship is the association of systemic and periodontal disease. Hashimotos thyroiditis has also been 
considered as one of the causes of periodontal disease. As a matter of fact, on an autoimmune basis, in Hashimotos 
disease and periodontal disease, we have made an attempt to derive the common mechanisms, with an evidence base. 
The need for this kind of review was due to the fact that the outcome of periodontal therapy did not give the expected 
results in patients with Hashimoto’s thyroiditis. Hence, a possible link between Hashimotos thyroiditis and periodontitis 
was considered.
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The cellular and molecular biology research tools in the 
field of pathobiology and immunology have revealed the 
importance of the host immune system, and have led to the 
understanding of the undesirable immunological responses 
in susceptible individuals.[1] Periodontitis is a multifactorial 
infectious disease caused by mixed microbiota. Apart 
from the microbial etiology a number of factors, namely, 
environmental and genetic factors, have been proposed, to 
modulate host microbial interactions that ultimately decide 
the clinical picture of periodontal disease.[2]
Indeed, animal and population-based studies now suggest 
that periodontal diseases may be linked with systemic 
diseases and conditions, including cardiovascular (CVS) 
diseases, diabetes, respiratory diseases, adverse pregnancy 
outcomes, and osteoporosis.[3]
In 1965, Brandtzaeg and Kraus were the first to postulate 
the autoimmune basis in the pathogenesis of periodontal 
disease. [4] The involvement of autoantibodies in the 
pathogenesis of aggressive periodontitis has been observed, 
suggesting the role of autoimmunity in periodontitis.[5] Few 
antinuclear cytoplasmic autoantibody (ANCA)-associated 
diseases are known to coexist with periodontitis in humans. 
Such diseases include Rheumatoid arthritis (RA) and to a 
lesser extent, systemic lupus erythematosus (SLE).[6]
Hashimotos thyroiditis (HT), a common autoimmune 
disease, presents with similar factors of disease progression. 
The strong association of periodontitis and other systemic 
conditions such as CVS disorders and preterm low birth 
weight babies, are systematically reviewed with the evidence 
base.[7,8] However, more studies are required to explore the 
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link between periodontitis and the autoimmune conditions 
and a probable common mechanism in these disease 
processes. This review revisits autoimmunity as a potential 
etiological basis for the pathogenesis of periodontal disease 
and also focuses on the current knowledge linking periodontal 
infection and Hashimotos Thyroiditis. Several hypotheses 
correlating to periodontal infection and Hashimotos 
thyroiditis are drawn with the evidence base, in this review.
Probable Common Autoimmune Mechanisms 
in Periodontitis and HT
•	 Role of antinuclear antibodies (ANA)
•	 Role of apoptosis
•	 Role of superantigens
Hashimoto's thyroiditis – Autoimmunity as a potential 
etiological basis
In 1912, Hashimoto described four patients with a 
chronic disorder of the thyroid, which he termed ‘struma 
lymphomatosa’. Hashimoto's thyroiditis (chronic autoimmune 
thyroiditis) is the most common cause of hypothyroidism in 
iodine-sufficient areas of the world. Thyroid failure is seen in 
up to 10% of the population and its prevalence increases with 
age.[9] It is characterized clinically by gradual thyroid failure, 
goiter formation, or both, due to autoimmune-mediated 
destruction of the thyroid gland involving apoptosis of the 
thyroid epithelial cells.[10] Nearly all patients have high serum 
concentrations of antibodies against one or more thyroid 
antigens, diffuse lymphocytic infiltration of the thyroid, which 
includes predominantly thyroid-specific B and T cells, and 
follicular destruction. [11] The cause of Hashimoto's thyroiditis 
is thought to be a combination of genetic susceptibility and 
environmental factors.[12,13]
Hashimoto’s thyroiditis is one of the most common 
human autoimmune diseases responsible for considerable 
morbidity. [14] Autoimmune failure of the thyroid requires 
several genetic and environmental abnormalities and 
is a multistep process to converge before the full-
blown disease develops. At the onset of disease, major 
histocompatibility complex (MHC) class II-positive antigen-
presenting cells (APC), particularly dendritic cells, and 
different subclasses of macrophages, accumulate in the 
thyroid.[15,16] APC present thyroid-specific autoantigens to 
the T cells, leading to activation and clonal expansion of the 
latter. Thus, the initial stage of the disease is followed by a 
clonal expansion phase and maturation of the autoreactive 
T and B lymphocytes in the draining lymph nodes. Taking 
up the relevant autoantigens, the APC travel from the 
thyroid to the draining lymph nodes. A central phase occurs 
in the draining lymph nodes, wherein interactions between 
APC, autoreactive (AR) T cells (that survive as result of 
dysregulation or breakage of immune tolerance), and B cells 
result in inducing the production of thyroid autoantibodies. 
In the next step, antigen-producing B lymphocytes, cytotoxic 
T cells, and macrophages infiltrate and accumulate in the 
thyroid, through expansion of the lymphocyte clones and 
propagation of lymphoid tissue within the thyroid gland. This 
process is preferentially mediated by the T-helper type 1 (TH1) 
cells, which secrete regulatory cytokines (interleukin-12, 
interferon-gamma γ and tumor necrosis factor-alpha. In a 
final stage, the generated autoreactive T cells, B cells, and 
antibodies cause massive depletion of the thyrocytes via 
antibody-dependent, cytokine-mediated, and apoptotic 
mechanisms of cytotoxity that leads to Hashimoto's disease.
[16]
Role of Environmental Factors in Autoimune 
Thyroiditis
Long-term iodine exposure leads to increased iodination 
of thyroglobulin, which increases its antigenicity and 
initiates the autoimmune process in genetically susceptible 
individuals. [17] Iodine is a necessary component of normal 
thyroid hormonogenesis. High iodine intake, selenium 
deficiency, pollutants such as tobacco smoke, infectious 
diseases such as chronic hepatitis C, and certain drugs are 
implicated in the development of autoimmune thyroiditis, 
primarily in the genetically predisposed.[18] It has been 
demonstrated that a highly iodinated thyroglobulin molecule 
is a better immunogen than a low iodine content.[18,19] 
Therefore, highly iodinated residues may facilitate antigen 
uptake and processing by APC. Similarly, high doses of 
iodine have shown to directly affect macrophages, dendritic 
cells, and B and T lymphocytes, resulting in the stimulation 
of macrophage myeloperoxidase activity, acceleration of 
the maturation of dendritic cells, increasing the number of 
circulating T cells, and stimulating B cell immunoglobulin 
production. [20] Excessive amounts of iodide ions are rapidly 
oxidized by Thyroid peroxidase (TPO), thereby generating 
excessive amounts of reactive intermediates such as 
hypoiodous acid and oxygen radicals. These oxidative species 
damage the thyrocyte cell membrane by oxidation of the 
membrane lipids and proteins, causing thyrocyte necrosis.[21]
Selenium deficiency decreases the activity of the selen-
oproteins, including glutathione peroxidases, which can 
lead to raised concentrations of hydrogen peroxide and thus 
promote inflammation and disease. Environmental pollutants 
such as smoke, polychlorinated biphenyls, solvents, and 
metals have been implicated in the autoimmune process 
and inflammation.[22]
Antinuclear Autoantibodies
Role of ANA in autoimmunity
Davis et al., documented anti-neutrophil cytoplasmic 
antibodies (ANCAs) for subjects with acute necrotizing 
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glomerulonephritis.[23] ANCAs represent a heterogeneous 
group of antibodies, also known as antinuclear factors 
(ANF).[24] These factors target antigens that are primarily 
present in the azurophil granules of polymorphonuclear 
leukocytes (PMNs). The role of ANCA is determined 
in several other known autoimmune diseases, such 
as, inflammatory conditions, infectious diseases, and 
neoplasms.[24] Few include systemic vasculitis, Wegener’s 
granulomatosis, Churg Strauss syndrome, classic polyarteritis 
nodosa, microscopic polyarteritis, rheumatoid arthritis, 
systemic lupus erythematosus, acute / chronic infection, 
HIV infection, and chronic periodontitis. Indirect 
immunofluorescence was advocated during the 1970s, to 
demonstrate granulocyte-specific antinuclear factors in 
sinovial fluids and the sera of RA patients.[25]
The tendency for all the chronic inflammation to undergo 
dysfunction could be related to the immune-specific genes, 
such as, alleles of human leukocyte antigens and the other 
genes that determine the level of the host immune response. In 
recent times, microbial superantigens (SAgs) and mechanisms 
related to disturbed apoptosis or removal of apoptotic cells have 
been proposed for the induction of ANCA.[26]
Antinuclear antibody testing
The ANA test was designed by Dr. George Friou, in 1957. 
The ANA test is performed using a blood sample. The 
antibodies in the serum of the blood are exposed to cells, 
in the laboratory. It is then determined whether or not 
antibodies are present that react to various parts of the 
nucleus of the cells. Fluorescence techniques are frequently 
used to actually detect the antibodies in the cells, thus 
ANA testing is sometimes referred to as the fluorescent 
antinuclear antibody test (FANA).[27] The ANA test is a 
sensitive screening test used to detect autoimmune diseases.
Role of ANA in autoimmune Hashimotos thyroiditis
Antinuclear antibodies have been detected in other non-
connective tissue disorder (CTD) autoimmune diseases, 
such as, autoimmune thyroiditis (also termed ‘chronic 
lymphocytic thyroiditis’ or ‘Hashimoto's thyroiditis’). The 
frequency of ANA positivity in children with autoimmune 
thyroiditis has been reported to be in the range of 30 to 
70%.[28]
In patients with autoimmune thyroiditis, the thyroid 
dysfunction might be induced by cytokine-mediated 
apoptosis of thyroid epithelial cells and the infiltrating T 
lymphocytes may not directly be involved in the thyrocyte 
cell death. However, fragmented DNA, a characteristic 
feature of apoptosis, was frequently found in the thyroid 
follicular cells in Hashimoto's thyroiditis.
Possible theories for the high association of ANA with 
autoimmune thyroiditis are, enhanced apoptosis of 
thyroid follicular cells, exposing nuclear antigens to elicit 
development of ANA, and B-cell hyperactivity with 
production of multiple autoantibodies.[29]
The ANCA Type for Hashimotos Thyroiditis has positive 
thyroid antibodies, ATG (Anti-thyroglobulin), ATPO 
(Anti-thyroid peroxidase), and ATPO, indicating the 
ANCA-mediated autoimmune thyroiditis (or Hashimoto's 
thyroiditis)[29] [Figure 1].
Evidence of the Autoimmune Basis of  
Periodontal Disease
The presence of auto-antibodies or antibodies against 
self-antigens has been investigated for their association 
with periodontal disease.[30] Elevated levels of antibody to 
collagen have been reported in the sera and are produced 
by the gingival tissues of the subjects with periodontal 
disease.31 Cells were observed, in the diseased gingival 
tissues, to produce an antibody to the collagen, only 
against the types of collagen present in those tissues.[31] 
Antibody specificity for collagen types I, III, IV, V, and 
VI were found, but not against type II collagen. Type II 
collagen was not commonly found in gingival tissues, 
suggesting that destruction of the collagen in the disease 
process may have caused the auto-antibody responses. 
The autoimmune condition, rheumatoid arthritis, was 
shown to be associated with an increased incidence of 
periodontal disease.[32] However, in a study of periodontal 
disease in elderly individuals, no increase in rheumatoid 
factor or incidence of anti-nuclear antibodies was found 
Figure 1: ANCA leading to HT
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to be associated with the disease.[32] However, in another 
study, the antinuclear antibody levels were higher in the 
periodontal disease subjects than in the controls, but 
no data were presented. Humoral immune response to 
Porphyromonas gingivalis in older adults with periodontal 
disease has also been reported.[33]
Role of ANA in periodontal pathogenesis
Studies are currently underway to study the potential 
pathogenic role of ANCA in periodontal tissue destruction. 
ANCA was first described by Parsons et al.,[34] in a condition 
of localized hyperplastic ‘strawberry’ gingival lesion, which 
was later diagnosed to be Wegener’s granulomatosis. A 
similar case was also recently reported by Manchanda 
et al.[35] The first controlled study to explore the possible link 
between ANCA and periodontal disease was conducted by 
Novo and Viera,[36] and a statistically significant number of 
ANCA-positive patients were reported in the periodontitis 
group than healthy controls. Although the mechanisms 
that trigger the development of ANCA are not completely 
understood, several hypotheses have been postulated, 
including immunospecific genes, such as alleles of human 
leukocyte antigens and other genes that determine the level 
of the host immune response.[37] In recent times, microbial 
superantigens (SAgs) and mechanisms related to disturbed 
apoptosis or removal of apoptotic cells have been proposed 
for the induction of ANCA.[38]
The two mechanisms that trigger ANCA are
1.	 Hyperprimed neutrophils produce myeloperoxidase 
(MPO) and proteinase-3 (PR-3), which triggers ANCA
2.	 The exposure of the host to periodontal pathogens, 
along with a genetic susceptibility, could trigger ANCA 
by TNF-alpha
3.	 The other known pathway is the ability of periodontal 
pathogens to possess a ‘superantigen’ property, where they 
can directly activate the autoreactive B-lymphocytes in 
a T-cell–independent and mediated pathway, which can 
also result in the production of ANCA.
Furthermore, these invoke an antigen antibody–
dependent immune response, which results in the 
activation of neutrophils. The activated neutrophils 
release reactive oxygen radicals, enzymes, and various 
proinflammatory cytokines, all of which are known to 
mediate periodontal destruction.[39] ANCA-activated 
neutrophils are also known to delay apoptosis, which can 
prolong the activity of neutrophils and thereby increase 
tissue destruction.
Role of apoptosis in autoimmunity
Autoimmune apoptosis of neutrophils is essential for 
controlling the duration of early inflammatory response 
and thus limiting local tissue damage, which can result 
from the prolonged activation of neutrophils. Utz and 
Anderson.[40] suggested that defects in apoptosis or in 
the process of removal of apoptotic cells could lead 
to exposure of these cellular fragments to the immune 
system and activate a humoral immune response. 
Further opsonization of these apoptotic neutrophils by 
ANCA might accelerate inflammation and augment the 
autoimmune response.[41]
Altered Apoptosis in Hashimotos Thyroiditis
Aberration in the regulatory mechanism of apoptosis 
is considered to be contributory to ANCA-associated 
autoimmune diseases, such as RA.[42] Furthermore, 
various proinflammatory cytokines such as tumor necrosis 
factor-alpha (TNF-a) and granulocyte monocyte colony 
stimulating factor (GM-CSF) are known to have a role in 
delaying neutrophil apoptosis, by altering the levels of Bcl-
2 proteins.[43,44] Such prolonged survival of neutrophils is 
associated with a sustained inflammatory response.
Certain responses against specific antigens are primary 
determinants in thyroid. The normal thyroid gland has been 
shown to act as an immune-privileged site, having carefully 
regulated mechanisms of cell death and self-protection 
against attack by infiltrating activated T-cells induced by 
apoptosis. [45,46] Cell apoptosis occurs in the normal thyroid at 
a low level, to maintain normal thyroid volume and function. 
Deregulation of apoptosis, which is weakly determined by 
genetic susceptibility, can lead to destructive processes. 
Initiation of an out-of-control apoptotic mechanism in the 
thyroid cells may be caused by various non-genetic injuries 
that affect the expression of the apoptosis inhibitor molecule 
Bcl-2 or membrane ligand FasL.[47] Thyrocytes from HT 
thyroid glands are able to hyperproduce Fas and FasL on 
their surfaces, thus inducing fratricide apoptosis.[48] IL-1β, 
abundantly produced in HT glands, induces Fas expression 
in normal thyrocytes; the cross-linking of Fas resulting in 
massive thyrocyte apoptosis. This can play a role in the 
progression of Hashimoto's thyroiditis.[49] Immune-mediated 
apoptosis of thyrocytes is directed by CD8+ cells. Receptors 
on the target cell are triggered by lymphocyte ligands and / 
or released soluble factors.[50]
The predominance of TH1 or TH2 cytokines might regulate 
thyrocyte survival through the induction of pro-apoptotic 
and anti-apoptotic proteins. TH1-mediated mechanisms lead 
to thyrocyte depletion in Hashimoto's thyroiditis, through 
the involvement of death receptors and cytokine-regulated 
apoptotic pathways.[51,52]
Role of apoptosis in periodontitis
Apoptosis is induced in the periodontal tissue by host 
and microbial factors, which supports the hypothesis 
that apoptotic mechanisms could be implicated in the 
inflammatory process associated with gingival tissue 
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destruction observed in adult periodontitis patients. [40] 
Recent studies have a reported association between 
hyperreactive neutrophils in the periodontal disease and 
an increased release of oxygen radicals in the periodontal 
damaged tissue. Neutrophil activity would produce a delay 
in the death of the cell by apoptosis, increasing the damage 
to the periodontal tissue. Gamonal et al. demonstrated 
aberrant, that is, accelerated or delayed neutrophil apoptosis, 
with a shift in balance between the mammalian Bcl-2 family 
of apoptosis-associated proteins, a reduction in the cellular 
(neutrophil) expression of proapoptotic protein Bax, and 
an elevated anti-apoptotic protein Bcl-253. In addition, 
they suggested that the presence of elevated levels of GM-
CSF and TNF-a in gingival crevicular fluid (GCF) from 
periodontitis sites relative to that of the healthy sites could 
also be attributed as the causative factor for the delay in 
neutrophil apoptosis.[54] Utz and Anderson[40] suggested that 
defects in apoptosis or in the process of removal of apoptotic 
cells could lead to exposure of these cellular fragments to the 
immune system, thus activating a humoral immune response.
Role of superantigens in autoimmunity
Superantigens are microbial or viral toxins that comprise of 
a class of disease-associated, immunostimulatory molecules 
and act as variant β (Vβ)-restricted extremely potent 
polyclonal T cell mitogens. Superantigens are unique, in 
that, they induce tremendous activation and expansion 
of specific subsets of T cells in an antigen-independent 
manner; thereby causing immune dysfunction. They bind 
the major histocompatibility complex (MHC) class-II 
molecules without any prior processing and stimulate a 
large number of T cells (up to 20% of all T cells) on the 
basis of the epitope specified by this receptor.[55,56] These 
properties are attributable to their unique ability to 
cross-link MHC class II and the T cell receptor (TCR), 
forming a trimolecular complex. The superantigens can be 
Endogenous[57-59] (produced by mouse mammary tumor virus 
and Epstein-Barr virus), Exogenous[57,58] (exotoxins secreted 
by microorganisms), and B-cell superantigens[60], which 
stimulate predominantly B cells.
Role of superantigens in periodontitis
Immunological research studies in periodontics have been 
directed toward determining superantigenic periodontal 
pathogens. Immunomodulation by periodontopathic bacteria 
has been implicated in the pathogenesis of inflammatory 
periodontal diseases. Zadeh HH[38] has provided evidence 
to support the hypothesis that a large proportion of T cells 
in periodontitis sites have been stimulated and expanded 
by superantigens, presumably produced by periodontitis-
associated bacteria, by demonstrating the elevated 
levels of proportion of one or a few V beta families. In 
another study Mathur et al.,[61] has studied the ability 
of Actinobacillus actinomycetemcomitans, Porphyromonas 
gingivalis, and Prevotella intermedia, to determine the SAg 
activity in vitro and has reported that only P. intermedia 
has the capacity to increase the expression of T-cell Vab2, 
Vb5, and Vb6, thereby providing evidence of the possible 
involvement of SAg in human periodontal diseases. Of 
late, a study by Leung and Torres[62] demonstrated that the 
P. intermedia strain, which is a clinical isolate, induced the 
strongest expansion of CD4 + T-cell subsets that express 
Vb8, Vb12, and Vb17 TCRs. Furthermore, to confirm 
the role of A. actinomycetemcomitans–derived SAg, 
Zadeh et al.,[63] reported that the response to this bacterial 
stimulus was a large-scale T-cell activation in a Vb-specific 
manner, demonstrating the superantigenic property by A. 
actinomycetemcomitans.[63] Thus, these studies specify a 
possibility of the role of superantigen in periodontitis.
Evidence for a Link Between Periodontitis and 
Hashimotos Thyroiditis
The two possible hypothetical models that can be drawn 
for the causal relationship of periodontitis and Hashimotos 
thyroiditis with evidence base include [Figure 2].
Autoimmune model
ANCA, cell apoptosis, superantigens activating autoreactive 
Figure 2: Common mechanisms in HT and periodontitis
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T-cells and B-cells with clonal expansion, followed by 
proinflammatory cytokines–mediated destruction further 
modified by genetic and environmental factors.[64]
Endothelial dysfunction model
leading to reduced caliber and a greater number and 
tortuosity of gingival capillary loops in the interdental 
region, observed in HT cases.[65] The altered gingival 
microcirculation compromises the first line of defense, 
with increased PGE and cytokines leading to periodontitis.
As the association of periodontitis and HT is from 
infancy, the possible role of autoimmunity in these two 
chronic conditions needs to be evaluated. Novo et al.,[36] 
found that ANCA was detectable in 10% of RA patients 
with periodontitis and 6.6% of RA patients without 
periodontitis. Studies in association with RA, SLE, and 
periodontitis have a similar natural history, etiology, 
pathogenesis, immune potential and progression patterns 
of the disease Some ANCA-associated diseases are known 
to coexist during periodontitis in humans. Such diseases 
include RA and SLE and to a lesser extent HT, which again 
holds good with these factors. Other common factors for 
these diseases include proinflammatory cytokine profiles 
such as IL-1, TNF-a, and prostaglandin E2, and a role 
for ROS.
To date, significant progress has been made in identifying 
and characterizing those components that frequently 
associate autoimmunity in periodontitis and other chronic 
conditions. Although HT is not a contributory factor 
because of its complexity, efforts to detect the possibility 
of risk factors are a key role in the identification of 
periodontal disease, with association of autoimmunity and 
HT. Endothelial dysfunction model [Figure 3].
Scardina and Messina[65] suggested a possible association of 
HT and periodontitis, in relation to the poor tissue response 
to periodontal therapy. Reduced caliber and a greater 
number and tortuosity of gingival capillary loops in the 
interdental region are observed in HT cases [Figure 3]. The 
clinical consequences of altered gingival microcirculation 
can be a compromise of the first line of defense. For the 
defense cells to perform their function, some receptors must 
be expressed in correspondence with the endothelial wall.
Thus, the first step of the non-specific defense involves a 
greater vulnerability in the subject. Such morphological 
data appear extremely relevant, as they would certainly 
be altered during particular pathologies, such as, HT. The 
endothelial dysfunction in these patients, presenting with 
low-grade chronic inflammation, impairs nitric oxide 
availability by a Cox-2 dependent pathway, leading to 
increased production of oxidative stress.[65] Oral findings 
include macroglossia65dysgeusia, delayed root resumption,[66] 
decreased salivary gland secretion,[67] poor periodontal 
health, delayed wound healing, and osteoarthritis of the 
temporomandibular joint (TMJ).[68] Recent studies have 
pointed to potentially periodontal risk indicators, however, 
no information is available on the impact of changes in the 
thyroid hormone levels on the progression of periodontitis and 
on the quality of the alveolar bone. D. S. Feitosa et al., thus, 
aimed to evaluate histologically, in rats, the influence of thyroid 
hormones on the rate of periodontal bone loss, resulting from 
ligature placement, and on the quality of the tooth-supporting 
alveolar bone. They concluded that decreased serum levels of 
Figure 3: A schematic presentation of HT and Periodontitis is shown
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thyroid hormones may enhance periodontitis-related bone 
loss, as a function of an increased number of resorbing cells, 
whereas, the tooth-supporting alveolar bone seems to be less 
sensitive to alterations in hormone levels.[69]
Stress or mood alteration are the characteristic features of HT. 
Evidence suggesting stress and periodontal disease is already 
stated.[70] Therefore a correlation of stress altering the blood 
flow and trafficking of inflammatory cells can induce a set 
of reactions that have effects on virtually all body systems. 
However association of HT, Stress, and Periodontitis need 
to be evaluated.





4.Gene test (HLA-antigens / MHC molecules)
Future Perspectives
The relationship of HT and periodontitis holds worthy 
for refractory periodontal disease with low plaque scores, 
uncontrolled periodontal disease, generalized aggressive 
periodontitis, and those with associated chronic conditions 
like RA and SLE. Anti-nuclear antibodies are found 
to be associated with HT and periodontitis. Hence, a 
future in periodontal medicine should be based upon the 
autoimmune nature of these chronic conditions in relation 
to periodontitis. Moreover, females are more susceptible to 
autoimmune disease than males. This is attributed to the 
high immune reactivity, due to sex hormones. Therefore, 
female patients diagnosed with recurrent and / or refractory 
periodontitis may possibly be associated with undiagnosed 
HT. Apart from that children are more susceptible to HT. 
Therefore, children presenting with periodontitis associated 
with systemic diseases can be referred to the physician for 
possible involvement of HT.
Thus, the clinical implication of understanding the possible 
link between HT and periodontitis can be realized from the 
fact that a stable and healthy periodontium can be achieved 
only when HT has been controlled / treated. Therefore, a 
periodontist needs to modify the therapeutic procedures 
depending on the underlying systemic condition, however, 
this review supports the hypothesis of an association between 
periodontitis and HT. Furthermore, research is needed on the 
possible impact of periodontitis on the HT condition.
Conclusions
More studies are required to explore the link between 
these conditions and a probable common mechanism in 
these disease processes. The causal relationship presents 
periodontal disease in a rather weak association, as one 
of the confounding factors. There exists a lack of control 
of the confounding factors, residual confounders, and 
over-control of cofounders. Categorization of the diseases, 
potential evidence to establish the etiologies, and possibly 
to diagnose and monitor disease activities is the goal of 
research conducts. As yet, this study is in its infancy. Future 
work, in the form of cohort studies and controlled studies 
are required. This area should concentrate on the functional 
mechanisms of the action of these autoantibodies, the critical 
immunogenic potential of ANAs, and on superantigens that 
play an important role in assessing periodontal disease with 
HT. Identification of the relationship of the autoantibody 
responses with the other immune and inflammatory 
mechanisms active during periodontal diseases is the key 
factor for diagnosis. Although at a very preliminary stage, 
the available data suggest that the autoantibody to specific 
periodontal pathogens and immune cells can modulate 
various aspects of periodontal disease.
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